The stock gapped up bullishly this morning and is now trading back toward the high of the day after a test lower. The 50-day moving average, last at $12.90, is major support. The stock came within range of that moving average on the move lower, and then quickly reacted back up. Resistance levels to watch as potential upside objectives are at $13.63, $13.88, $14.10. The $14 area has been major resistance for the stock through most of the year. A breakout above that area would therefore be very bullish. :theflyonthewall.com
News For AMLN From The Last 14 Days
Check below for free stories on AMLN the last two weeks.
There are 12 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
Amylin Pharma is recently down 25c to $17.73 The FDA is expected to make a decision on the company's LAR (EQW-exenatide once weekly diabetes treatment) by March 5, 2010. February put option implied volatility is at 48, March puts are at 77, April is at 74; verses its 26-week average of 68 according to Track Data, suggesting larger March price movement. :theflyonthewall.com
Subscribe for More Information
